Patent · US Active

Method of producing an immunoligand/payload conjugate

US11986535B2 · kind B2 · utility

0Cited by

9References

23Claims

0Family size

Assignee

NBE-Therapeutics AG · CH

Inventors

Ulf Grawunder · Basel, CH
Roger Beerli · Adlikon, CH

Key dates

Filing date	Jun 13, 2022
Grant date	May 21, 2024
Priority date	—
Expiry date	Jun 13, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2521/537
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a method of producing an immunoligand/payload conjugate, which method encompasses conjugating a payload to an immunoligand by means of a sequence-specific transpeptidase, or a catalytic domain thereof (Fig. 6b).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.